These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38908788)

  • 1. Gut microbiota dynamics and association with chronic kidney disease: A longitudinal study within the PREDIMED-Plus trial.
    Atzeni A; Díaz-López A; Cacho AH; Babio N; García-Gavilán JF; Cornejo-Pareja I; Belzer C; Fitó M; Tinahones FJ; Salas-Salvadó J
    Life Sci; 2024 Aug; 351():122863. PubMed ID: 38908788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the gut microbiota in patients with chronic kidney disease.
    Hu X; Ouyang S; Xie Y; Gong Z; Du J
    Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
    [No Abstract]   [Full Text] [Related]  

  • 3. Longitudinal Pilot Evaluation of the Gut Microbiota Comparing Patients With and Without Chronic Kidney Disease.
    Pourafshar S; Sharma B; Allen J; Hoang M; Lee H; Dressman H; Tyson CC; Mallawaarachchi I; Kumar P; Ma JZ; Lin PH; Scialla JJ
    J Ren Nutr; 2024 Jul; 34(4):302-312. PubMed ID: 38286361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
    Li F; Wang M; Wang J; Li R; Zhang Y
    Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accessing the relationship between six surrogate insulin resistance indexes and the incidence of rapid kidney function decline and the progression to chronic kidney disease among middle-aged and older adults in China: Results from the China health and retirement longitudinal study.
    Liu S; Sun H; Liu J; Wang G
    Diabetes Res Clin Pract; 2024 Jun; 212():111705. PubMed ID: 38735539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered gut microbiota and microbial biomarkers associated with chronic kidney disease.
    Lun H; Yang W; Zhao S; Jiang M; Xu M; Liu F; Wang Y
    Microbiologyopen; 2019 Apr; 8(4):e00678. PubMed ID: 30088332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of estimated glomerular filtration rates in Chinese patients with chronic kidney disease among serum creatinine-, cystatin-C- and creatinine-cystatin-C-based equations: A retrospective cross-sectional study.
    Hu J; Xu X; Zhang K; Li Y; Zheng J; Chen W; Wang X
    Clin Chim Acta; 2020 Jun; 505():34-42. PubMed ID: 32027887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects].
    Guirong YE; Minjie Z; Lixin YU; Junsheng YE; Lin Y; Lisha S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1401-1408. PubMed ID: 30613005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations?
    Terpos E; Christoulas D; Kastritis E; Katodritou E; Pouli A; Michalis E; Papassotiriou I; Dimopoulos MA;
    Eur J Haematol; 2013 Oct; 91(4):347-55. PubMed ID: 23829647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women.
    Malmgren L; McGuigan FE; Christensson A; Akesson KE
    Nephron; 2020; 144(6):290-298. PubMed ID: 32392561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compositional and Functional Adaptations of Intestinal Microbiota and Related Metabolites in CKD Patients Receiving Dietary Protein Restriction.
    Wu IW; Lee CC; Hsu HJ; Sun CY; Chen YC; Yang KJ; Yang CW; Chung WH; Lai HC; Chang LC; Su SC
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease.
    Beetham KS; Howden EJ; Isbel NM; Coombes JS
    BMC Nephrol; 2018 Dec; 19(1):366. PubMed ID: 30563479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equations.
    Rothenbacher D; Klenk J; Denkinger M; Karakas M; Nikolaus T; Peter R; Koenig W;
    BMC Public Health; 2012 May; 12():343. PubMed ID: 22574773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical association between the metabolite of healthy gut microbiota, 3-indolepropionic acid and chronic kidney disease.
    Sun CY; Lin CJ; Pan HC; Lee CC; Lu SC; Hsieh YT; Huang SY; Huang HY
    Clin Nutr; 2019 Dec; 38(6):2945-2948. PubMed ID: 30612852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the utility of cystatin C as a confirmatory test of chronic kidney disease across the age range in middle-aged and older community-dwelling adults.
    Canney M; Sexton DJ; O'Leary N; Healy M; Kenny RA; Little MA; O'Seaghdha CM
    J Epidemiol Community Health; 2018 Apr; 72(4):287-293. PubMed ID: 29332011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index.
    Vupputuri S; Fox CS; Coresh J; Woodward M; Muntner P
    Am J Kidney Dis; 2009 Jun; 53(6):993-1001. PubMed ID: 19394726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients.
    Steubl D; Block M; Herbst V; Nockher WA; Schlumberger W; Satanovskij R; Angermann S; Hasenau AL; Stecher L; Heemann U; Renders L; Scherberich J
    Medicine (Baltimore); 2016 Mar; 95(10):e3011. PubMed ID: 26962815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrepant glomerular filtration rate trends from creatinine and cystatin C in patients with chronic kidney disease: results from the KNOW-CKD cohort.
    Kang E; Han SS; Kim J; Park SK; Chung W; Oh YK; Chae DW; Kim YS; Ahn C; Oh KH
    BMC Nephrol; 2020 Jul; 21(1):280. PubMed ID: 32677901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.